Clinical Trial Update: S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 3]

View source ↗

Summary

This document reports the completed Phase 3 trial S9916 evaluating the combination of docetaxel and estramustine in men with advanced prostate cancer that has n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Estramustine phosphate sodium (Estramustine phosphate sodium)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED